Hyalogic

Hyalogic, founded in 2001, is a prominent player in the E-Commerce, Health Care, Manufacturing, and Pharmaceutical industries. The company specializes in premium high molecular weight hyaluronic acid products, offering joint care supplements for humans and animals, as well as a full line of skin care and personal care products made with premium hyaluronic acid (HA). Also known as hyaluronan or hyaluronate, HA supports healthy joints and has numerous skin, hair, nail, and eye moisturizing benefits. Hyalogic's diverse product line includes liquid oral supplements, lozenge supplements, and topical skin care products under well-known names such as Synthovial Seven and Episilk, as well as Hyakun for horses and HyaFlex for dogs or cats. The company is headquartered in the United States. As of now, there is no publicly available information regarding the last investment or the investors involved in Hyalogic. However, with its innovative product range and strong presence in multiple sectors, the company presents an intriguing investment opportunity for venture capitalists seeking to tap into the e-commerce, healthcare, and pharmaceutical markets.